Impact of the SRC inhibitor dasatinib on the metastatic phenotype of human prostate cancer cells.
about
Androgen receptor activation in castration-recurrent prostate cancer: the role of Src-family and Ack1 tyrosine kinasesSRC: marker or actor in prostate cancer aggressivenessA phase I trial of KX2-391, a novel non-ATP competitive substrate-pocket- directed SRC inhibitor, in patients with advanced malignancies.A randomized phase II study of cediranib alone versus cediranib in combination with dasatinib in docetaxel resistant, castration resistant prostate cancer patients.Osteolytic bone metastasis is hampered by impinging on the interplay among autophagy, anoikis and ossification.Transcription Factor STAT3 as a Novel Molecular Target for Cancer Prevention.Combined BRAF(V600E)- and SRC-inhibition induces apoptosis, evokes an immune response and reduces tumor growth in an immunocompetent orthotopic mouse model of anaplastic thyroid cancer.Differential requirement for Src family tyrosine kinases in the initiation, progression, and metastasis of prostate cancerImproved angiostatic activity of dasatinib by modulation with hydrophobic chainsModulation of the tumor vasculature and oxygenation to improve therapySrc-signaling interference impairs the dissemination of blood-borne tumor cellsTranscriptional repression of VEGF by ZNF24: mechanistic studies and vascular consequences in vivo.Molecularly targeted agents as radiosensitizers in cancer therapy--focus on prostate cancer.Novel roles of Src in cancer cell epithelial-to-mesenchymal transition, vascular permeability, microinvasion and metastasis.Therapeutic modulation of prostate cancer metastasis.Meaningful prevention of breast cancer metastasis: candidate therapeutics, preclinical validation, and clinical trial concerns.Recepteur d'origine nantais (RON), more than a kinase: Role in castrate-resistant prostate cancer.Overcoming EMT-associated resistance to anti-cancer drugs via Src/FAK pathway inhibition.Adaptive metabolic rewiring to chronic SFK inhibitionProgression-related loss of stromal Caveolin 1 levels fosters the growth of human PC3 xenografts and mediates radiation resistanceAC-93253 iodide, a novel Src inhibitor, suppresses NSCLC progression by modulating multiple Src-related signaling pathways.Antcin-H Isolated from Antrodia cinnamomea Inhibits Renal Cancer Cell Invasion Partly through Inactivation of FAK-ERK-C/EBP-β/c-Fos-MMP-7 Pathways.Doxorubicin delivered by a redox-responsive dasatinib-containing polymeric prodrug carrier for combination therapy.
P2860
Q26866135-663F6FB6-17FB-41A9-B205-FB09CFA56D36Q27012541-E6424E88-BAFB-4B4A-91B7-14C06C42238FQ33405571-4A5F5708-2E89-4A12-AAFF-4E8632387097Q33415009-75C8540D-9B90-41DA-B88F-6E4D0B1ABF63Q33695021-A9F13D60-8777-44CD-8E7D-8AF9C083E2BCQ33820278-1CED0DB2-F881-4FEB-BDA0-BA94F7BD7494Q34100838-0169B555-F5AF-4908-8D64-B4A9724ADA93Q34364815-806A9567-1B70-4CF8-ADF4-3B69BFCC7E7AQ35178869-5625D7E0-442B-4C8B-B724-670BADEBE54CQ35920685-02CB2764-7057-407C-9B58-8D8C04ED95E1Q36153123-40899AFA-21FA-4E22-8795-EFA50AD43224Q36569678-037581E1-9D38-4ADB-824D-F357631A60E5Q37092020-3E3579B7-8CB5-4D25-A98F-EB47E44ACB95Q37116160-28252380-9806-4F08-9703-71E30ABE1A01Q38182140-905FC0A1-6434-48DA-96B7-7BBD71C7A540Q38269966-1E98A77F-569F-4085-B1FF-B1689F8455A5Q38543678-C0453CE0-C7BB-45FB-9455-B96956EF4E48Q38959291-C908A350-10D3-4CFB-A6F4-F0231C86C8A7Q41878889-63DFF956-4CBD-45F6-8953-DB71A0E4B260Q42121834-B8EF092F-BD2A-4174-A644-DFAB2A4D3FBFQ46752829-1A767BEF-90DC-436B-BF3A-1D05DC83DC69Q47131124-E6A9B5B2-1DD8-46F0-A652-804D1A808D25Q50643010-EB6E8C20-DA7A-431E-B498-F948446BE833
P2860
Impact of the SRC inhibitor dasatinib on the metastatic phenotype of human prostate cancer cells.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Impact of the SRC inhibitor da ...... f human prostate cancer cells.
@en
Impact of the SRC inhibitor da ...... f human prostate cancer cells.
@nl
type
label
Impact of the SRC inhibitor da ...... f human prostate cancer cells.
@en
Impact of the SRC inhibitor da ...... f human prostate cancer cells.
@nl
prefLabel
Impact of the SRC inhibitor da ...... f human prostate cancer cells.
@en
Impact of the SRC inhibitor da ...... f human prostate cancer cells.
@nl
P2093
P2860
P1476
Impact of the SRC inhibitor da ...... f human prostate cancer cells.
@en
P2093
Christina Pampo
Dietmar W Siemann
Sharon Lepler
P2860
P2888
P304
P356
10.1007/S10585-011-9436-2
P577
2011-12-01T00:00:00Z